- €2.05bn
- €3.07bn
- €3.25bn
- 54
- 57
- 47
- 52
2019 December 31st | R2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | PRESS | ARS | ARS | ARS |
Standards: | IFRS | — | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 3,671 | 2,792 | 3,668 | 5,014 | 3,251 |
Cost of Revenue | |||||
Gross Profit | 839 | 1,925 | 2,706 | 3,519 | 2,150 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 3,454 | 2,768 | 2,795 | 3,986 | 3,624 |
Operating Profit | 217 | 24 | 873 | 1,028 | -373 |
Total Net Non Operating Interest Income / Expense | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 82 | -49 | 889 | 1,194 | 100 |
Provision for Income Taxes | |||||
Net Income After Taxes | -145 | -160 | 791 | 930 | 12 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | -184 | -675 | 298 | 740 | 109 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -184 | -675 | 298 | 740 | 109 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -3.9 | -0.285 | 22.5 | 37.6 | 14.8 |
Dividends per Share |